XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

CAMBRIDGE, Mass., June 29, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced an expansion of its research collaboration with Pfizer…

XtalPi, Pfizer Expand AI-Powered Drug Discovery Collaboration ...

Pfizer (NYSE:PFE) Expands Collaboration With XtalPi To Enhance Drug Discovery Platform

Pfizer (NYSE:PFE) experienced a 2.98% price move over the past month, coinciding with new strategic collaborations. Notably, the company's expanded research partnership with XtalPi aims to advance drug discovery technologies, which could enhance long-term innovation prospects. Additionally, its involvement in the FIBRE Consortium and positive Phase 3 study results for products like HYMPAVZI™ highlight progress in product development. These devel…

XtalPi and Pfizer Expand Collaboration to Advance AI Drug Discovery

XtalPi, an AI and robotics to revolutionize drug and materials discovery, announced an expanded research collaboration with Pfizer

Evotec Joins Consortium to Revolutionize Kidney Injury Drug Discovery

Evotec (EVO) has recently joined the NURTuRE-AKI Consortium, a global collaboration of leading research institutions and pharmaceutical companies, in an effort to advance drug discovery for acute kidney injury (AKI). This move marks a significant step in the fight against kidney disease, which affects millions of people worldwide and has a high mortality rate. AKI is a common complication in hospitalized patients and can lead to severe kidney da…